These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7619921)

  • 1. Developments in the treatment of leukaemias and lymphomas.
    Ann Hematol; 1995 Jun; 68(3 Suppl):1-8. PubMed ID: 7619921
    [No Abstract]   [Full Text] [Related]  

  • 2. [New analogs of deoxyadenosine for treatment of lymphoid malignancies].
    Robak T
    Przegl Lek; 1992; 49(10):355-8. PubMed ID: 1364050
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative efficacy of the newer nucleosides (fludarabine, 2'-deoxycoformycin, and 2-chlorodeoxyadenosine) in the treatment of indolent lymphoid malignancies.
    Saven A
    Semin Hematol; 1993 Oct; 30(4 Suppl 6):31-3. PubMed ID: 7908757
    [No Abstract]   [Full Text] [Related]  

  • 4. Current trends in chemotherapy of leukaemias lymphomas and multiple myeloma.
    Kasili EG
    East Afr Med J; 1976 Sep; 53(9):554-9. PubMed ID: 1009883
    [No Abstract]   [Full Text] [Related]  

  • 5. [Nucleoside analogues--new drugs for the treatment of lymphatic cancers].
    Itälä M; Remes K
    Duodecim; 2001; 117(2):162-9. PubMed ID: 12092367
    [No Abstract]   [Full Text] [Related]  

  • 6. Purine analogs in leukemia.
    Lamanna N; Weiss M
    Adv Pharmacol; 2004; 51():107-25. PubMed ID: 15464907
    [No Abstract]   [Full Text] [Related]  

  • 7. CML after treatment for lymphoid malignancy: Therapy-related CML or coincidence?
    Bolaños-Meade J; Sarkodee-Adoo C; Khanwani SL
    Am J Hematol; 2002 Oct; 71(2):139. PubMed ID: 12353319
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical pharmacology of fludarabine].
    Robak T; Drzewoski J
    Pol Tyg Lek; 1991 Dec 2-9; 46(48-49):942-4. PubMed ID: 1845714
    [No Abstract]   [Full Text] [Related]  

  • 9. Perspectives on purine analogues.
    Cheson BD
    Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S109-16. PubMed ID: 9137964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fludarabine in the treatment of chronic lymphocytic leukemia and other lymphoproliferative disorders].
    Pawelski S
    Acta Haematol Pol; 1995; 26(3):263-8. PubMed ID: 8525771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fludarabine therapy in patients with splenic lymphoma with villous lymphocytes: an update.
    Lefrère F; Lévy V; François S; Delarue R; Ifrah N; Tilly H; Valensi F; Troussard X; Varet B; Hermine O
    Leukemia; 2004 Nov; 18(11):1924-5. PubMed ID: 15385943
    [No Abstract]   [Full Text] [Related]  

  • 12. Fludarabine in lymphoproliferative malignancies: a single-centre experience.
    Prabhash K; Vikram GS; Nair R; Sengar M; Gujral S; Bakshi A; Gupta S; Parikh PM
    Natl Med J India; 2008; 21(4):171-4. PubMed ID: 19267037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical overview of pentostatin (Nipent) use in lymphoid malignancies.
    Dearden CE; Matutes E; Catovsky D
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):22-6. PubMed ID: 10877047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs in leukemia.
    Croce C
    Clin Adv Hematol Oncol; 2006 Aug; 4(8):577-8. PubMed ID: 17099614
    [No Abstract]   [Full Text] [Related]  

  • 15. Introduction: evolution of targeted and multifunctional agents for leukemias and lymphomas.
    Tallman MS
    Semin Hematol; 2008 Jul; 45(3 Suppl 2):S1. PubMed ID: 18760703
    [No Abstract]   [Full Text] [Related]  

  • 16. Fludarabine-related myeloid leukemia.
    Astrow AB
    J Clin Oncol; 2003 Oct; 21(19):3709; author reply 3709-10. PubMed ID: 14512411
    [No Abstract]   [Full Text] [Related]  

  • 17. Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphoma.
    Grigg A; Bardy P; Byron K; Seymour JF; Szer J
    Bone Marrow Transplant; 1999 Jan; 23(2):107-10. PubMed ID: 10197793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Richter's syndrome--the downside of fludarabine?
    Hamblin TJ
    Leuk Res; 2005 Oct; 29(10):1103-4. PubMed ID: 16111529
    [No Abstract]   [Full Text] [Related]  

  • 19. Fludarabine for chronic lymphocytic leukemia.
    Erman M; Celik I; Tekuzman G
    N Engl J Med; 2001 Apr; 344(15):1166; author reply 1167-8. PubMed ID: 11302142
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia.
    Dizdar O; Yürekli BS; Pürnak T; Aksu S; Haznedaroglu IC
    Ann Pharmacother; 2004; 38(7-8):1319-20. PubMed ID: 15138295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.